Ascending cholangitis cost-effectiveness of therapy

Ascending cholangitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Ascending cholangitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ascending cholangitis cost-effectiveness of therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ascending cholangitis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ascending cholangitis cost-effectiveness of therapy
CDC on Ascending cholangitis cost-effectiveness of therapy
Ascending cholangitis cost-effectiveness of therapy in the news
Blogs on Ascending cholangitis cost-effectiveness of therapy
Directions to Hospitals Treating Ascending cholangitis
Risk calculators and risk factors for Ascending cholangitis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

Early ERCP is considered safe as well as cost-effective in the treatment of mild to moderate ascending cholangitis

Cost effectiveness of therapy for ascending cholangitis

According to some studies, early ERCP is considered safe as well as cost effective in the treatment of mild to moderate ascending cholangitis. It reduces the duration of hospital stay and antibiotics are needed for fewer days thus making it a cost effective intervention